Innovec Biotherapeutics
InnoVecBio is a company focused on solving gene delivery challenges across all human tissues and organs by developing precise, safe, and efficient tissue-targeted vectors. This enables gene therapy to be widely applicable to various patient populations. The company leverages AI to develop its EASI-AAV platform, creating vectors targeting the retina, nervous system, and muscles, with gene therapy drugs based on these vectors progressing towards clinical trials. InnoVecBio aims to become a world-leading, technology-driven company in gene therapy, addressing core technical issues and making gene therapy products accessible to the public. They have achieved national high-tech enterprise status and have established a postdoctoral workstation.
Innovec Biotherapeutics
InnoVecBio is a company focused on solving gene delivery challenges across all human tissues and organs by developing precise, safe, and efficient tissue-targeted vectors. This enables gene therapy to be widely applicable to various patient populations. The company leverages AI to develop its EASI-AAV platform, creating vectors targeting the retina, nervous system, and muscles, with gene therapy drugs based on these vectors progressing towards clinical trials. InnoVecBio aims to become a world-leading, technology-driven company in gene therapy, addressing core technical issues and making gene therapy products accessible to the public. They have achieved national high-tech enterprise status and have established a postdoctoral workstation.